SCHEMBL7779813

SCHEMBL7779813

C=CCn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(C)cc2)c1CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 12/20 0.47
PTGS2 P35354 9/20 0.47
CA2 P00918 8/20 0.47
CA1 P00915 7/20 0.47
CA4 P22748 2/20 0.45
PTGS1 P23219 4/20 0.43
CA12 O43570 9/20 0.43
CA3 P07451 2/20 0.40
CA6 P23280 2/20 0.40
CA5A P35218 2/20 0.40
CA7 P43166 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
MT-CO2 P00403 1/20 0.40
LMNA P02545 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780739 0.90 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL7779631 0.89 PTGS2 (0.47) CA9PTGS2CA2CA1CA4
SCHEMBL7780021 0.86 PTGS2 (0.49) CA9PTGS2CA2CA1CA4
SCHEMBL7779903 0.86 PTGS2 (0.55) CA9PTGS2CA2CA1CA4
SCHEMBL7772871 0.84 KMT2A (0.46) CA9PTGS2CA2CA1CA4
SCHEMBL7780018 0.83 CA9 (0.47) CA9PTGS2CA2CA1CA4
SCHEMBL7778098 0.82 PTGS2 (0.43) CA9PTGS2CA2CA1CA4
SCHEMBL7779625 0.82 PTGS2 (0.51) CA9PTGS2CA2CA1CA4
SCHEMBL7777654 0.82 PTGS2 (0.45) CA9PTGS2CA2CA1CA4
SCHEMBL7777557 0.82 PTGS2 (0.48) CA9PTGS2CA2CA1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed